Full Library

Return to list of results

Chimeric Antigen Receptor Therapy

RIS

Recommended format for most reference management software

BibTeX

Recommended format for BibTeX-specific software

Open in Zotero
View on zotero.org
Resource type
Journal Article
Authors/contributors
Title
Chimeric Antigen Receptor Therapy
Abstract
Chimeric Antigen Receptor T Cells This review addresses T-cell engineering and synthetic immunity, with a focus on producing durable remissions in patients with treatment-refractory tumors. Toxic effects of chimeric antigen receptor therapies include cytokine release syndrome and neurologic dysfunction.
Publication
New England Journal of Medicine
Date
July 5, 2018
Volume
379
Issue
1
Pages
64-73
DOI
10.1056/NEJMra1706169
URL
https://doi.org/10.1056/NEJMra1706169
Accessed
2/15/20, 2:34 PM
ISSN
0028-4793
Library Catalog
Taylor and Francis+NEJM
Extra
PMID: 29972754
Citation
June, C. H., & Sadelain, M. (2018). Chimeric Antigen Receptor Therapy. New England Journal of Medicine, 379(1), 64–73. https://doi.org/10.1056/NEJMra1706169
HEME-ONC AND CELLULAR THERAPIES
Link to this record
https://www.transplantid.net/PJX5IUPW